Improving Medication Adherence in Older African Americans With Diabetes

Completed · Not applicable

Conditions studied: Type 2 Diabetes, Mild Cognitive Impairment

In brief

This research aims to help older African Americans with diabetes and mild memory problems improve how they take their medications and control their diabetes. This may preserve their independence and health, prevent cognitive and functional decline, and reduce health care costs. As the population ages and becomes more racially diverse, finding ways to achieve these outcomes has great public health importance.

Key facts

Study ID

NCT02174562

Run by

Thomas Jefferson University

People needed

101

Starts

2014-07-01

Expected to finish

2019-12-01

Last updated by the study team

2020-08-10

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 60 years and older.
• Self-identified as African American, black, black American, or black/Caribbean.
• Type II DM (i.e., physician diagnosis and medication treatment).
• HbA1c level ≥ 7.5%.
• MCI, based on National Institute on Aging/Alzheimer's Association (NIA/AA) criteria.
• ≤ 80% adherence to an oral hypoglycemic medication or insuling, as documented during a run-in phase using a Medication Event Monitoring System (MEMS).

You may not qualify if…

• Dementia, based on National Institute on Aging/Alzheimer's Association criteria.
• DSM-V psychiatric disorder other than depressive disorders.
• End-stage renal disease requiring dialysis.
• Hearing/Vision (i.e., severe diabetic retinopathy) or motor (e.g., peripheral neuropathy) impairment that precludes research participation.

Where it is running

• Thomas Jefferson University — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.